Tech & Pharma
The clinical trial will test the efficacy of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in patients suffering from homozygous familial hypercholesterolemia.
The 330,000 square foot facility will allow Alcon to rapidly respond to the needs of consumers in Asia.
Bosch has invested US$2.2 million in the larger Musashi site to meet the demand for pharmaceutical inspection technologies.
Spinifex Pharmaceuticals will use the investment to run clinical trials for EMA401, an oral treatment for pain that has been shown not to have central nervous system side effects.
China received the most investment for renewable energies in 2013, while Japan’s renewable energy market grew the fastest.
Bayer’s US$139 million investment will make the Beijing site their largest pharmaceuticals packaging facility in China.
IBM invests US$100 million to develop ten Interactive Experience labs around the world, including five in Asia.
The US$3.2 billion transaction will form the largest pharmaceutical company in India and the fifth largest specialty generics manufacturer in the world.
One year after its launch, the data from Vietnam’s VNREDSat-1 has contributed to the country’s safety and economy.
Developed using cell culture-based technology, Takeda’s H5N1 vaccine could help to strengthen Japan’s pandemic preparedness.